Raloxifene examined for breast cancer prevention.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Subject Terms:
      UNITED States. Food & Drug Administration
    • Abstract:
      The article reports that raloxifene examined for breast cancer prevention in the U.S. The Food and Drug Administration (FDA) advisory panel gave its approval for the osteoporosis drug raloxifene to be used as an oral chemopreventive agent for invasive breast cancer. The panelists said that the drug should be available as an alternative to tamoxifen. Furthermore, many members of the Oncologic Drugs Advisory Committee urged regulators to impose safeguards on the use raloxifene.